Preprint
Discovery of the first genome-wide significant risk loci for ADHD
Affiliations
Organisations
- (1) Aarhus University, grid.7048.b, AU
- (2) Lundbeck Foundation, grid.452548.a
- (3) Massachusetts General Hospital, grid.32224.35
- (4) Broad Institute, grid.66859.34
- (5) Karolinska Institute, grid.4714.6
- (6) Cardiff University, grid.5600.3
- (7) Stockholm Health Care Services, grid.467087.a
- (8) State Serum Institute, grid.6203.7
- (9) Metabolomx (United States), grid.435694.9
- (10) University of California, Los Angeles, grid.19006.3e
- (11) Institute of Biological Psychiatry, MHC Sct. Hans, Mental Health Services Copenhagen, Roskilde, Denmark
- (12) Genomics plc, Oxford, United Kingdom
- (13) Charité, grid.6363.0
- (14) Boston University, grid.189504.1
- (15) Oslo University Hospital, grid.55325.34
- (16) University of Toronto, grid.17063.33
- (17) EMGO Institute for Health and Care Research, grid.466632.3
- (18) Amsterdam Neuroscience, grid.484519.5
- (19) Biomedical Network Research Centre on Rare Diseases (CIBERER), Barcelona, Spain
- (20) University of Barcelona, grid.5841.8
- (21) Hospital Sant Joan de Déu Barcelona, grid.411160.3
- (22) Departments of Human Genetics (855) and Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands
- (23) Veterans Affairs Connecticut Healthcare Center, West Haven, Connecticut, USA
- (24) Yale University, grid.47100.32
- (25) Children's Hospital of Philadelphia, grid.239552.a
- (26) National Institutes of Health Clinical Center, grid.410305.3
- (27) University of Pennsylvania, grid.25879.31
- (28) King's College London, grid.13097.3c
- (29) Maastricht University, grid.5012.6
- (30) University of Würzburg, grid.8379.5
- (31) Child and Youth Mental Health Service, Children’s Health Queensland Hospital and Health Service, Brisbane, Australia
- (32) University of Queensland, grid.1003.2
- (33) University Hospital Frankfurt, grid.411088.4
- (34) Federal University of Rio Grande do Sul, grid.8532.c
- (35) Hospital de Clínicas de Porto Alegre, grid.414449.8
- (36) James J Peters VA Medical Center, grid.274295.f
- (37) Icahn School of Medicine at Mount Sinai, grid.59734.3c
- (38) Ghent University, grid.5342.0
- (39) University of Southampton, grid.5491.9
- (40) University of North Carolina System, grid.410711.2
- (41) University of Copenhagen, grid.5254.6, KU
- (42) Aarhus University Hospital, grid.154185.c, Central Denmark Region
- (43) SUNY Upstate Medical University, grid.411023.5
Countries
Continents
Description
Abstract Attention-Deficit/Hyperactivity Disorder (ADHD) is a highly heritable childhood behavioral disorder affecting 5% of school-age children and 2.5% of adults. Common genetic variants contribute substantially to ADHD susceptibility, but no individual variants have been robustly associated with ADHD. We report a genome-wide association meta-analysis of 20,183 ADHD cases and 35,191 controls that identifies variants surpassing genome-wide significance in 12 independent loci, revealing new and important information on the underlying biology of ADHD. Associations are enriched in evolutionarily constrained genomic regions and loss-of-function intolerant genes, as well as around brain-expressed regulatory marks. These findings, based on clinical interviews and/or medical records are supported by additional analyses of a self-reported ADHD sample and a study of quantitative measures of ADHD symptoms in the population. Meta-analyzing these data with our primary scan yielded a total of 16 genome-wide significant loci. The results support the hypothesis that clinical diagnosis of ADHD is an extreme expression of one or more continuous heritable traits.